LaVoieHealthScience

Alphabetical Index | Geographical Index | Specialty Index

---

LaVoieHealthScience

20 Park Plaza, Suite 312, Boston, MA 02116

617/374-8800

schoe@lavoiehealthscience.com

https://lavoiehealthscience.com
Strategic communications including public relations, investor relations and corporate communications, as well as marketing and digital communications.

Employees: 15. Founded: 2001.

Agency Statement:

(L to R) Sharon Correia, EVP, strategy and integrated communications; Lisa Descenza, VP, integrated communications; Paul Sagan, VP, IR & corp. comms; Donna L. LaVoie, president & CEO; Ella Deych, VP, finance and chief operations officer; Sharon Choe, SVP, investor access and bus dev; Douglas Russell, SVP, client service & PR/media; Harriet Ulmann, AVP, PR & product communications

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications, access and marketing. With two decades of industry-tested counsel to more than 375 clients, we provide public relations, investor relations and strategic consulting to build recognition and increase sales and value for health science innovations.

The agency has received over 50 awards in recognition of the work it has done helping health and science innovators, from development to launch and commercialization, to connect with key stakeholders. We help advance health and science innovations by providing specialized thinking to clients throughout the company and product life cycle building innovation and value for humankind. We offer direct connections to media, investors, partners, advocacy groups, and KOLs. We are focused on building trust and long-term relationships based on the quality of the work that we deliver. In January 2020, LHS and Omnicom Public Relations Group (OPRG), a division of Omnicom Group (NYSE: OMC), formed a strategic alliance to bring global clients a broader set of integrated health- and science-experienced teams.

Donna L. LaVoie, pres. & CEO; Douglas Russell, sr. VP & gen. mgr.; Sharon Correia, sr. VP, integrated comms.; Sharon Choe, sr. VP, IR & BD; Paul Sagan, asst. VP, IR & corp. comms.; Lisa DeScenza, asst. VP, integrated comms.; Ella Deych, VP, finance & opers.

58 Greenpoint Ave., Brooklyn, NY 11222
Sharon Choe
917/945-2068

Clients Include:

AC Immune SA
Biotechnology Innovation Association
Newron Pharmaceuticals SpA
Nuritas
Venthera
Celavie Biosciences
TriSalus Life Sciences
Ocugen
Omega Therapeutics
Outlook Therapeutics
Protalix Biotherapeutics
SIRION Biotech
TFF Pharmaceuticals
TG Therapeutics
Xontogeny LLC

 Printer Friendly